Enhanced expression of melanoma progression markers in mouse model of sleep apnea

Revista Portuguesa De Pneumologia
S PeriniCintia Zappe Fiori

Abstract

Obstructive sleep apnea has been associated with higher cancer incidence and mortality. Increased melanoma aggressivity was reported in obstructive sleep apnea patients. Mice exposed to intermittent hypoxia (IH) mimicking sleep apnea show enhanced melanoma growth. Markers of melanoma progression have not been investigated in this model. The present study examined whether IH affects markers of melanoma tumor progression. Mice were exposed to isocapnic IH to a nadir of 8% oxygen fraction for 14 days. One million B16F10 melanoma cells were injected subcutaneously. Immunohistochemistry staining for Ki-67, PCNA, S100-beta, HMB-45, Melan-A, TGF-beta, Caspase-1, and HIF-1alpha were quantified using Photoshop. Percentage of positive area stained was higher in IH than sham IH group for Caspase-1, Ki-67, PCNA, and Melan-A. The greater expression of several markers of tumor aggressiveness, including markers of ribosomal RNA transcription (Ki-67) and of DNA synthesis (PCNA), in mice exposed to isocapnic IH than in controls provide molecular evidence for a apnea-cancer relationship. These findings have potential repercussions in the understanding of differences in clinical course of tumors in obstructive sleep apnea patients. Further invest...Continue Reading

References

Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Nov 14, 1997·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·H A LehrA M Gown
Oct 6, 2005·Journal of Cellular Physiology·Jörn BullwinkelThomas Scholzen
May 22, 2007·Cell·George-Lucian MoldovanStefan Jentsch
Feb 9, 2008·Cell Death and Differentiation·E B Rankin, A J Giaccia
Feb 3, 2009·Angiogenesis·Sébastien ToffoliCarine Michiels
Mar 26, 2009·Journal of the National Cancer Institute·Bonnie E Gould RothbergDavid L Rimm
Dec 10, 2009·Folia Histochemica Et Cytobiologica·Jolanta CzyzewskaRoman Bandurski
Jan 21, 2010·Physiological Reviews·Jerome A DempseyChristopher P O'Donnell
Jan 22, 2010·International Journal of Cancer. Journal International Du Cancer·Einar K RofstadKanthi Galappathi
Oct 21, 2010·Lipids in Health and Disease·Denis MartinezÂngelo Bos
Jun 30, 2011·AIDS Patient Care and STDs·Lisa B Hightow-WeidmanUNKNOWN YMSM of Color SPNS Initiative Study Group
Jan 3, 2012·The European Respiratory Journal·I AlmendrosR Farré
Nov 6, 2012·Respiratory Physiology & Neurobiology·Diego BaronioMarcelle Reesink Cerski
Nov 17, 2012·American Journal of Respiratory and Critical Care Medicine·Francisco Campos-RodriguezUNKNOWN Spanish Sleep Network
Mar 19, 2013·Respiratory Physiology & Neurobiology·Isaac AlmendrosRamon Farré
Jul 11, 2013·Histopathology·Tine M Søland, Ingvild J Brusevold
Dec 18, 2013·Sleep & Breathing = Schlaf & Atmung·Cintia Zappe FioriAlicia Carissimi
Jan 30, 2014·American Journal of Respiratory and Critical Care Medicine·Isaac AlmendrosDavid Gozal
Mar 25, 2014·The European Respiratory Journal·Miguel-Ángel Martínez-GarcíaRamón Farré
Apr 16, 2014·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Nathaniel S MarshallRonald R Grunstein
Aug 7, 2014·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Tetyana KendzerskaAndrea S Gershon

❮ Previous
Next ❯

Citations

Oct 13, 2016·Annual Review of Medicine·Diane C Lim, Allan I Pack
Nov 26, 2020·International Journal of Molecular Sciences·David GozalRamon Farré

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.